Navigation Links
Douglas Harrington, MD Addresses Select Group Of Physicians Regarding Latest Advances In Cardiovascular Risk Assessment
Date:3/19/2013

SAN FRANCISCO, March 19, 2013 /PRNewswire/ -- Aviir Inc., a biotechnology company dedicated to enhanced detection and prevention of cardiovascular disease through innovative diagnostic tests, announced that Douglas Harrington , MD, Clinical Professor of Pathology at USC and Aviir Inc. CEO, addressed a select group of physicians and leading cardiologists on the Latest Advances in Cardiovascular Risk Assessment at a special invitation-only reception in San Francisco. The event took place March 10, during the American College of Cardiology (ACC) 2013 Annual Conference and included guest speakers Thomas Quertermous , PhD, Professor of Cardiovascular Medicine from the Stanford University School of Medicine, and Americo Simonini , MD, Cardiologist at Cedars-Sinai Medical Center.

(Logo: http://photos.prnewswire.com/prnh/20130319/LA79677LOGO)

"Our goal is to present and discuss the best cardiac risk assessment methods available. Presenting next generation tests like MIRISK VP™ with fellow physicians in an intimate forum enabled a free exchange and the chance to discuss advances in the field of preventative cardiology," said Dr. Harrington.

Many physicians at the event elected to take the MIRISK VP test on-site, which was offered by GUARDaHEART, a national non-profit dedicated to heart disease awareness and prevention.

MIRISK VP stratifies the intermediate risk group, which has proven to be a critical part of risk assessment, as most adverse cardiac events happen to intermediate risk individuals. In fact, MIRISK VP was shown in a peer-reviewed publication to significantly improve cardiac risk assessment by reclassifying intermediate risk individuals to either high or low risk groups, resulting in a net reclassificat
'/>"/>

SOURCE Aviir Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. BioHealth Innovation, Inc. Appoints Qiagens Douglas Liu to Board of Directors
2. Aviir, Inc.s CEO Dr. Douglas Harrington Delivered The Facts Surrounding Heart Disease At The Los Angeles Ultimate Womens Expo
3. Dr. James Douglas Adds Human Growth Hormone (HGH) Therapy to IVF Protocols for Poor Responding Patients
4. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
7. Webcor Builders Selected as the General Contractor for First Phase of LA BioMeds New Campus Master Plan
8. Sequenom Named to NASDAQ Global Select Market
9. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
10. First Choice Rehabilitation Specialists Joins Select Medical
11. Netsmart Selects Overland Park, Kansas, for New Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... , Oct. 20, 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ... million which brings Q3 orders to $5.8 million and provides a ... projects in North America and one in ... to bid new projects at record levels," said Peter Bruijns ... higher at the end of Q3 than they have been for ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
(Date:10/20/2014)... October 20, 2014 Local veterinary surgeon, ... an investigational study of donor stem cells for dogs ... cell therapy and has performed clinical stem cell therapy ... is to determine if a single injection of donor ... can help reduce pain and inflammation in the treated ...
(Date:10/19/2014)... NextCODE Health, which enables clinicians and researchers to use full ... the launch of its new genomic data analysis and collaboration ... of Human Genetics (ASHG) annual meeting in San ... for free beta access, visit www.nextcode.com . A brief ... here . The Exchange: , ...
Breaking Biology Technology:PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 2The NextCODE Exchange: The first global, real-time system for sharing full-resolution genomic data 3
... February 25 Arpida Ltd,(SIX: ARPN) announced today its financial results for the ... - Setback in regulatory process for intravenous iclaprim in ... - Top-line results of "intravenous-to-oral" Phase II trial with ... - Leadership change, - Share placing, ...
... Cerimon Pharmaceuticals, Inc., announced today the Company has enrolled ... patch Phase III program. The program consists of ... Cerimon,s diclofenac patch. The studies will assess the ... placebo for the treatment of acute pain caused by ...
... Speid & Associates, an international regulatory and drug ... entered into a partnership with Genizon BioSciences to ... Genizon,s proprietary genetic platform. In this challenging ... companies have to watch every dollar that is ...
Cached Biology Technology:Arpida Announces Full Year 2008 Financial Results 2Arpida Announces Full Year 2008 Financial Results 3Arpida Announces Full Year 2008 Financial Results 4Arpida Announces Full Year 2008 Financial Results 5Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain 2Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds 2
(Date:10/15/2014)... pneumonia in female mice to an enzyme activated by ... more resistant to respiratory infections than males. Now, an ... to bacterial pneumonia in female mice is linked to ... show that this enzyme is ultimately activated by the ... team, lead by Professor Lester Kobzik at the Harvard ...
(Date:10/14/2014)... shows SIRT6—a protein known to inhibit the growth ... skin cancers by turning on an enzyme that increases ... Previously considered protective, SIRT6 is part of a family ... stability and prevent some of the genetic flaws associated ... lead to cancer. This study, in the journal,s October ...
(Date:10/14/2014)... fish oil supplements, rich in omega-3 fatty acids, do not ... which the heart can beat as fast as 150 beats ... the Montreal Heart Institute were published in the Journal ... , For the trial, 337 patients with atrial fibrillation not ... of fish oil a day or to placebo for up ...
Breaking Biology News(10 mins):Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
... more attractive to women seeking short-term relationships, scientists at ... previously assumed that in Western cultures scarring was an ... perceived as a sign of maturity and strength. ... that Western women find scarring on men attractive and ...
... the presidential campaign, Barack Obama proposed an economic plan ... These so-called "green collar" jobs do, in fact, present ... report from Duke University. , Highlighting the direct ... say U.S. manufacturing is poised to grow in a ...
... A new study confirms that exercise can reverse the ... in the hippocampus of the mouse brain, and suggests ... which promotes the production and maturation of new stem ... into a variety of mature nerve cells which have ...
Cached Biology News:Scientists find facial scars increase attractiveness 2Duke study pinpoints potential 'green collar' job growth in US 2Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age 2Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age 3
RABBIT ANTI PARATHION...
Similar to proteasome (prosome, macropain) 26S subunit, ATPase, 1 Antigen: Recombinant Protein...
Homo sapiens HCLS1 associated protein X-1 Antigen: Recombinant Protein...
Amino Acid Analysis is performed using ion-exchange separation of the amino acids from acid hydrolysates, followed by ninhydrin detection. Typical quantities required are 0.1 to 0.5 mg, depending on...
Biology Products: